Smoking Cessation Resource Center Helping professionals help their patients quit smoking Home Our Products Literature Resources GSK Commitment Contact Us
Clinical Studies

Commit

Efficacy of a Nicotine Lozenge for Smoking Cessation
Saul Shiffman, PhD; Carolyn M. Dresler, MD; Peter Hajek, PhD; Simon J. A. Gilburt, PhD; Darren A. Targett, MSc; Kenneth R. Strahs, PhD
October 15, 2001
>>Click here to view study abstract

Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy
Saul Shiffman, Carolyn M. Dresler & Jeffrey M. Rohay
June 13, 2003
>>Click here to view study abstract

Nicotine patch and lozenge are effective for women
Saul Shiffman, Christine T. Sweeney, Carolyn M. Dresler
June 21, 2004
>>Click here to view study abstract

Nicotine lozenge efficacy in light smokers
Saul Shiffman
August 24, 2004
>>Click here to view study abstract

^ Back to top


NicoDerm CQ

Nicotine Patch Therapy in Smoking Cessation Reduces the Extend of Exercise-Induced Myocardial Ischemia
John J. Mahmarian, MD, FACC, Lemuel A. Moye, MD, PhD, George A. Nasser, MD, FACC, Sherif F. Nagueh, MD, FACC, Marilyn F. Bloom, RN, Neal L. Benowitz, MD, Mario S. Verani, MD, FACC, William G. Byrd, PharmD, Craig M. Pratt, MD, FACC
July, 1997
>>Click here to view study abstract

Efficacy of the nicotine patch for relief of craving and withdrawal 7-10 weeks after cessation
Saul Shiffman, Moise Khayrallah, Robert Nowak
February, 2000
>>Click here to view study abstract

A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches
Reginald V. Fant, Jack E. Henningfield, Saul Shiffman, Kenneth R. Strahs, Donald P. Reitberg
July 17, 2000
>>Click here to view study abstract

Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving
S. Shiffman, C. A. Elash, S. M. Paton, C. J. Gwaltney, J. A. Paty, D. B. Clark, K. S. Liu & M. E. Di Marino
August, 2000
>>Click here to view study abstract

The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy
S. Shiffman, J.A. Paty, J.M. Rohay, M.E. Di Marino, J.G. Gitchell
November 16, 2000
>>Click here to view study abstract

Risk of Acute First Myocardial Infarction and Use of Nicotine Patches in a General Population
Stephen E. Kimmel, MD, MS, FACC, Jesse A. Berlin, ScD, Carolyn Miles, MPH, Jane Jaskowiak, BSN, RN, Jeffrey L. Carson, MD, Brian L. Strom, MD, MPH
April, 2001
>>Click here to view study abstract

Efficacy of over-the-counter nicotine patch
Saul Shiffman, Jane Gorsline, Charles W. Gorodetzky
October 1, 2001
>>Click here to view study abstract

Real-world efficacy of prescription and over-the-counter nicotine replacement therapy
Saul Shiffman, Clyde N. Rolf, Stephen J. Hellebusch, Jane Gorsline, Charles W. Gorodetzky, Yu-Kun Chiang, Debra S. Schleusener & Michael E. Di Marino
November 27, 2001
>>Click here to view study abstract

Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample
S Shiffman, J R Hughes, J L Pillitteri, S L Burton
May 7, 2003
>>Click here to view study abstract

Nicotine patch and lozenge are effective for women
Saul Shiffman, Christine T. Sweeney, Carolyn M. Dresler
June 21, 2004
>>Click here to view study abstract

Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy
Victor J. Strecher, Saul Shiffman & Robert West
November 22, 2004
>>Click here to view study abstract


^ Back to top


Nicorette

Safety of Nicotine Polacrilex Gum Used by 3,094 Participants in the Lung Health Study
Robert P. Murray, PhD; William C. Bailey, MD, FCCP; Kathleen Daniels, MS; Wendy M. Bjornson, MPH; Karole Kurnow, MS; John E. Connett, PhD; Mitchell A. Nides, PhD; and James P. Kiley, PhD; for the Lung Health Study Research Group
February 1996
>>Click here to view study abstract

The Efficacy of Computer-Tailored Smoking Cessation Material as a Supplement to Nicotine Polacrilex Gum Therapy
Saul Shiffman, PhD; Jean A. Paty, PhD; Jeffrey M. Rohay, MS; Michael E. Di Marino, MA; Joe Gitchell, BA
November 1, 1999
>>Click here to view study abstract

Real-world efficacy of prescription and over-the-counter nicotine replacement therapy
Saul Shiffman, Clyde N. Rolf, Stephen J. Hellebusch, Jane Gorsline, Charles W. Gorodetzky, Yu-Kun Chiang, Debra S. Schleusener & Michael E. Di Marino
November 27, 2001
>>Click here to view study abstract

Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving
Saul Shiffman, William G. Shadel, Raymond Niaura, Moise A. Khayrallah, Douglas E. Jorenby, Charles F. Ryan, Clifford L. Ferguson
February 5, 2003
>>Click here to view study abstract

Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample
S Shiffman, J R Hughes, J L Pillitteri, S L Burton
May 7, 2003
>>Click here to view study abstract

Patterns of over-the-counter nicotine gum use: persistent use and concurrent smoking
Saul Shiffman, John R. Hughes, Michael E. Di Marino & Christine T. Sweeney
June 27, 2003
>>Click here to view study abstract

The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality
Nicholas R. Anthonisen, MD; Melissa A. Skeans, MS; Robert A. Wise, MD; Jure Manfreda, MD; Richard E. Kanner, MD; and John E. Connett, PhD, for the Lung Health Study Research Group
February 15, 2005
>>Click here to view study abstract


^ Back to top





Clinical Studies Smoking Cessation Patient Materials Newsletter for Healthcare Professionals
GlaxoSmithKline Consumer Healthcare Commit NicoDerm CQ Nicorette


This site is intended for U.S. healthcare professionals only · Privacy Statement · Copyright © GlaxoSmithKline.